Background <p>Uterine after pain is a common yet under-addressed postpartum complaint. This study aimed to investigate whether early postpartum supplementation with vitamins D and E could reduce the intensity and duration of uterine after pain in multiparous women.</p> Methods <p>This double-blind, parallel-group randomized clinical trial was conducted between October and December 2022 at Shahid Mobini Hospital in Sabzevar, Iran. One hundred eligible multiparous women were randomly assigned to receive either eight capsules containing 100&#xa0;mg of vitamin E and 400 IU of vitamin D over the first 48&#xa0;h postpartum or matched placebo capsules. Pain intensity was assessed via the visual analog scale (VAS), beginning 2&#xa0;h after delivery and subsequently at 6-hour intervals across eight time points. The duration of pain was measured via the Cox Menstrual Symptom Scale (CMSS). Data analysis was performed via SPSS version 16, with statistical significance set at <i>P</i> &lt; 0.05.</p> Results <p>No significant differences in pain intensity or duration at baseline were detected between the groups (<i>P</i> = 0.58 and <i>P</i> = 0.06, respectively). From the third time point onward, participants in the intervention group reported significantly lower pain intensity than did those in the placebo group (<i>P</i> &lt; 0.001). A similar trend was observed for pain duration, with a statistically significant reduction starting from the second time point in the intervention group (<i>P</i> &lt; 0.001).</p> Conclusion <p>Supplementation with vitamins E and D during the early postpartum period may serve as a safe, effective, and accessible strategy for reducing the intensity and duration of uterine after pain in multiparous women. These findings support the integration of targeted micronutrient therapy into postpartum pain management protocols.</p> Trial registration <p>Iranian Registry of Clinical Trials (IRCT): IRCT20220313054270N1.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

The effect of early postpartum vitamin d and e supplementation on uterine after pain: a double-blind randomized clinical trial

  • SeyedehZahra HosseiniHaji,
  • Roya Baghani,
  • Mina Ghalenovi,
  • Narjes Forouhar,
  • Maryam Aradmehr

摘要

Background

Uterine after pain is a common yet under-addressed postpartum complaint. This study aimed to investigate whether early postpartum supplementation with vitamins D and E could reduce the intensity and duration of uterine after pain in multiparous women.

Methods

This double-blind, parallel-group randomized clinical trial was conducted between October and December 2022 at Shahid Mobini Hospital in Sabzevar, Iran. One hundred eligible multiparous women were randomly assigned to receive either eight capsules containing 100 mg of vitamin E and 400 IU of vitamin D over the first 48 h postpartum or matched placebo capsules. Pain intensity was assessed via the visual analog scale (VAS), beginning 2 h after delivery and subsequently at 6-hour intervals across eight time points. The duration of pain was measured via the Cox Menstrual Symptom Scale (CMSS). Data analysis was performed via SPSS version 16, with statistical significance set at P < 0.05.

Results

No significant differences in pain intensity or duration at baseline were detected between the groups (P = 0.58 and P = 0.06, respectively). From the third time point onward, participants in the intervention group reported significantly lower pain intensity than did those in the placebo group (P < 0.001). A similar trend was observed for pain duration, with a statistically significant reduction starting from the second time point in the intervention group (P < 0.001).

Conclusion

Supplementation with vitamins E and D during the early postpartum period may serve as a safe, effective, and accessible strategy for reducing the intensity and duration of uterine after pain in multiparous women. These findings support the integration of targeted micronutrient therapy into postpartum pain management protocols.

Trial registration

Iranian Registry of Clinical Trials (IRCT): IRCT20220313054270N1.